[First death case of serotonin syndrome in Japan induced by fluvoxamine and tandospirone]

Chudoku Kenkyu. 2011 Dec;24(4):305-10.
[Article in Japanese]

Abstract

We experienced the first death case of the serotonin syndrome in Japan caused by fluvoxamine and tandospirone. A 15-year-old man was transported to our hospital for shock, muscle hypertonia and hyperthermia after cardiopulmonary arrest. His serum concentrations of fluvoxamine and tandospirone were 3,554 ng/mL and 698 ng/mL respectively after 24 hours from oral intake. He was dead in spite of intensive treatments. The progress of the serotonin syndrome is usually rapid. So, it should be monitored appropriately a patient with serotonin syndrome. If he has hyperthermia, immediate paralysis should be induced. We should aware of the serotonin syndrome a case of overdose on a serotonergic agent.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adolescent
  • Anti-Anxiety Agents / adverse effects*
  • Anti-Anxiety Agents / blood
  • Drug Overdose
  • Fatal Outcome
  • Fever / chemically induced*
  • Fluvoxamine / adverse effects*
  • Fluvoxamine / blood
  • Heart Arrest / chemically induced
  • Humans
  • Isoindoles / adverse effects*
  • Isoindoles / blood
  • Japan
  • Male
  • Muscle Hypertonia / chemically induced*
  • Piperazines / adverse effects*
  • Piperazines / blood
  • Pyrimidines / adverse effects*
  • Pyrimidines / blood
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / blood
  • Serotonin Receptor Agonists / adverse effects*
  • Serotonin Receptor Agonists / blood
  • Severity of Illness Index
  • Shock / chemically induced
  • Syndrome

Substances

  • Anti-Anxiety Agents
  • Isoindoles
  • Piperazines
  • Pyrimidines
  • Serotonin Receptor Agonists
  • Serotonin Uptake Inhibitors
  • tandospirone
  • Fluvoxamine